EGFR and glioblastoma: EGFR is present in more than 50% of the GBM, along with other active mutated variants like variant II (EGFRvII), III (EGFRvIII), and IV (EGFRvIV), involved in tumoral progression, angiogenesis, and treatment resistance [77].